Back
Regions Financial Vs. Intra-Cellular Therapies Industry Stock Comparison
Sell
43
RF
Regions Financial
Last Price:
19.26
Seasonality Move:
0.1%
Sell
37
ITCI
Intra-Cellular Therapies
Last Price:
71.85
Seasonality Move:
4.56%
Sell
43
Regions Financial (RF)
is a Sell
Is Regions Financial a Buy, Sell or Hold?
- The current Regions Financial [RF] share price is $19.27. The Score for RF is 43, which is 14% below its historic median score of 50, and infers higher risk than normal.
- RF is currently trading in the 40-50% percentile range relative to its historical Stock Score levels.
- This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.
Sell
37
Intra-Cellular Therapies (ITCI)
is a Sell
Is Intra-Cellular Therapies a Buy, Sell or Hold?
- The current Intra-Cellular Therapies [ITCI] share price is $71.80. The Score for ITCI is 37, which is 26% below its historic median score of 50, and infers higher risk than normal.
- ITCI is currently trading in the 30-40% percentile range relative to its historical Stock Score levels.
- This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.
RF Stock Price Chart
What is Regions Financial's stock price today?
-
The Regions Financial share price today is $19.27
Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and RF is experiencing selling pressure, which indicates risk of future bearish movement.
ITCI Stock Price Chart
What is Intra-Cellular Therapies's stock price today?
-
The Intra-Cellular Therapies share price today is $71.80
The current trend is moderately bullish and ITCI is experiencing slight selling pressure.
RF Technical Analysis
Chart Indicators | Level | Buy or Sell |
---|---|---|
MACD (12, 26): | -0.04 | Sell |
Relative Strength Index (14 RSI): | 46.16 | Sell |
Chaikin Money Flow: | -4983159 | - |
Bollinger Bands | Level | Buy or Sell |
---|---|---|
Bollinger Bands (25): | (19.11 - 20.37) | Sell |
Bollinger Bands (100): | (18.23 - 19.83) | Buy |
ITCI Technical Analysis
Chart Indicators | Level | Buy or Sell |
---|---|---|
MACD (12, 26): | 1.24 | Buy |
Relative Strength Index (14 RSI): | 52.15 | Buy |
Chaikin Money Flow: | -266083 | - |
Bollinger Bands | Level | Buy or Sell |
---|---|---|
Bollinger Bands (25): | ( - ) | Buy |
Bollinger Bands (100): | ( - ) | Buy |
RF Moving Averages
Moving Averages | Level | Buy or Sell |
---|---|---|
8-day SMA: | 19.42 | Sell |
20-day SMA: | 19.55 | Sell |
50-day SMA: | 19.42 | Sell |
200-day SMA: | 18.29 | Buy |
8-day EMA: | 19.45 | Sell |
20-day EMA: | 19.5 | Sell |
50-day EMA: | 19.35 | Sell |
200-day EMA: | 18.73 | Buy |
ITCI Moving Averages
Moving Averages | Level | Buy or Sell |
---|---|---|
8-day SMA: | 72.95 | Sell |
20-day SMA: | 70.87 | Buy |
50-day SMA: | 69.32 | Buy |
200-day SMA: | 62.37 | Buy |
8-day EMA: | 72.47 | Sell |
20-day EMA: | 71.37 | Buy |
50-day EMA: | 69.74 | Buy |
200-day EMA: | 64.22 | Buy |
Regions Financial Earnings Growth & RF Earnings Dates
- Analysts estimate an earnings decrease this quarter of $0.07 per share, an increase next quarter of $0.03 per share, a decrease this year of $0.26 per share, and an increase next year of $0.23 per share.
Intra-Cellular Therapies Earnings Growth & ITCI Earnings Dates
- Analysts estimate an earnings increase this quarter of $0.45 per share, a decrease next quarter of $0.07 per share, an increase this year of $0.98 per share, and an increase next year of $1.45 per share.
Regions Financial Technical Analysis
Apr 17 | Apr 18 | Apr 19 | Apr 22 | Apr 23 | Apr 24 | Apr 25 | Apr 26 | Apr 29 | Apr 30 | |
---|---|---|---|---|---|---|---|---|---|---|
Apr | ||||||||||
17 | 18 | 19 | 22 | 23 | 24 | 25 | 26 | 29 | 30 | |
Technical Analysis: Buy or Sell? | ||||||||||
8-day SMA: | ||||||||||
20-day SMA: | ||||||||||
50-day SMA: | ||||||||||
200-day SMA: | ||||||||||
8-day EMA: | ||||||||||
20-day EMA: | ||||||||||
50-day EMA: | ||||||||||
200-day EMA: | ||||||||||
MACD (12, 26): | ||||||||||
Relative Strength Index (14 RSI): | ||||||||||
Bollinger Bands (25): | ||||||||||
Bollinger Bands (100): |
Intra-Cellular Therapies Technical Analysis
Apr 17 | Apr 18 | Apr 19 | Apr 22 | Apr 23 | Apr 24 | Apr 25 | Apr 26 | Apr 29 | Apr 30 | |
---|---|---|---|---|---|---|---|---|---|---|
Apr | ||||||||||
17 | 18 | 19 | 22 | 23 | 24 | 25 | 26 | 29 | 30 | |
Technical Analysis: Buy or Sell? | ||||||||||
8-day SMA: | ||||||||||
20-day SMA: | ||||||||||
50-day SMA: | ||||||||||
200-day SMA: | ||||||||||
8-day EMA: | ||||||||||
20-day EMA: | ||||||||||
50-day EMA: | ||||||||||
200-day EMA: | ||||||||||
MACD (12, 26): | ||||||||||
Relative Strength Index (14 RSI): | ||||||||||
Bollinger Bands (25): | ||||||||||
Bollinger Bands (100): |